Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olanzapine and Riluzole for Loss of Appetite in ALS
NCT00876772Phase 3Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Mar 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of olanzapine, sponsored by Charité – Universitätsmedizin Berlin. Started Mar 2011; status: completed.
02
Drugs
olanzapine
Beyond the preview
Go deeper on NCT00876772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00876772.